Mispro News

Mispro Adds IVIS Imaging to Support In Vivo Research for Early-Stage Biotech Companies

IVIS-imaging-at-mispro

For early-stage biotech companies, access to specialized imaging technologies like IVIS for in vivo studies is often limited by cost and availability. Integrating complex imaging equipment and technical support directly into the research process is rarely possible without outsourcing, making technologies like IVIS among the most difficult capabilities to access during early discovery.

Mispro has changed that at its Kendall Main Street location, where teams can now access on-site IVIS capabilities alongside specialized research infrastructure designed to support early-stage in vivo studies. Researchers working here can incorporate real-time imaging directly into their studies, capturing data that strengthens findings and supports the next steps in their research.

A New Standard in Early-Stage Contract Vivarium Facilities in Boston

Mispro’s Kendall Main Street vivarium facility is located in the heart of Tech Square, offering easy access to Kendall Square biotech companies. For early-stage teams launching or currently outsourcing in vivo rodent studies, the location makes it a practical, low-friction extension of nearby lab and office space.

As an alternative to a CRO, Mispro’s contract vivarium model allows teams to maintain control of their studies, ensuring disciplined timelines, predictable spend, and 100% IP ownership. With built-in vivarium services including animal husbandry, veterinary, and regulatory compliance oversight, plus additional technical services that cover everything from biomethodology to surgical support, research teams have access to a comprehensive research environment without relying on outsourced services. This helps teams avoid the long wait times often associated with having studies picked up and results returned.

On-Site Imaging with In-House Control

With the addition of on-site IVIS imaging and other specialized equipment for in vivo studies, Mispro’s Kendall Main Street location now gives early-stage companies access to advanced imaging and technical infrastructure within the same contract vivarium environment where their studies are running. This helps simplify one of the biggest operational considerations when selecting a research partner. For teams working in oncology, infectious disease, gene therapy, and other areas where real-time visualization of biological processes is central to the work, having IVIS available in the same facility where studies are running changes what's operationally possible.

“IVIS is a capability that even well-resourced in vivo programs typically outsource,” said Paul Chamberlain, Associate Director, Technical Operations at Mispro. “Having it available in-house, within the same facility where your studies are running, changes what early-stage companies can realistically access from day one.”

For companies working at this Mispro location, imaging can now be scheduled and executed within the same workflow as the rest of a study, without coordinating with an outside vendor, shipping samples, or waiting on availability at another site. The data stays in-house, the timeline stays intact, and the team stays in control.

Clients can operate the IVIS system independently as part of their standard space rental. Those who need support can include imaging through Mispro's Technical Services, with Mispro staff handling the procedure on their behalf.

IVIS for Proof-of-Concept Data in Early-Stage Biotech

For seed-stage biotech companies that need in vivo data to win additional funding but don't yet have the team to generate it, Mispro offers a unique program at the Tech Square location.

Mispro's Seed-to-Scale program enables proof-of-concept (POC) data in 90 days through founder-led studies supported by enhanced technical services, support, and equipment access, including IVIS. With this offering, Mispro's technical staff handles up to 80% of the hands-on study work, while the client team retains full scientific control and data ownership. When investors start asking questions about study results, founders can have confidence that both the data and the process behind the study were observed, documented, and validated by the founder-led team from start to finish.

For early-stage startups on a seed-funded timeline, that validation matters. As studies grow in scope and additional funding is won, teams can move into Mispro's traditional contract vivarium model within the same facility to maintain the integrity of the study conditions and keep integral timepoints on schedule.

Technical Services Built to Support Early-Stage Teams

Beyond IVIS, Mispro's Technical Services team at the Kendall Main Street location supports early-stage companies with a broad range of in vivo study needs. Credentialed technicians are available to support research teams across biomethodology, including blood collection, dosing, and clinical observations, necropsy and tissue collection, surgical support, including pre- and post-operative care, and breeding colony management.

For startups generating their first in vivo data, having this depth of support on-site means studies can move forward without gaps in capability or delays waiting on outside resources.

Available Now in Kendall Square

On-site IVIS imaging is now available at Mispro’s Kendall Main Street location in Tech Square, with many existing and new clients already incorporating it into their in-house studies. The next Seed-to-Scale cohort is launching soon, with limited availability by design to ensure each team receives the dedicated support the program is built around.

Learn more about Seed-to-Scale